Skip to content

Treatment of chronic rhinosinusitis with polyposis using umbilical cord stem cells

Investigating the effect of intramucosal injection of exosomes derived from umbilical cord mesenchymal stem cells on the treatment of chronic rhinosinusitis with polyposis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130812014333N228
Enrollment
20
Registered
2024-10-07
Start date
2024-10-21
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic rhinosinusitis. Chronic sinusitis, unspecified

Interventions

Intervention 1: In the intervention group, exosomes derived from mesenchymal stem cells are injected into the polyp and nasal mucosa. The patients are treated for at least 1 month with the standard tr

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Validation of diagnostic criteria for chronic rhinosinusitis with polyposis Age over 18 years and less than 70 years failure of a previous course of standard treatment informed consent nasal congestion runny nose reduction of smell Obtaining a score of at least 4 out of 8 in the endoscopic scoring criteria based on polyp size (polyps are in the middle saatus and below the lower margin of the middle turbinate)

Exclusion criteria

Exclusion criteria: Suffering from other diseases Uncontrolled high blood pressure Severe coronary artery disease Chronic kidney failure, liver dysfunction, acute respiratory disease and acute infection Nasal septum problems History of smoking and pregnancy

Design outcomes

Primary

MeasureTime frame
Symptoms of allergy. Timepoint: At the beginning of the study, 1 week, 2 weeks and then 1, 2, 3 and 6 months after the end of the study. Method of measurement: Questions from the patient.;Polyp size change. Timepoint: At the beginning of the study, 1 week, 2 weeks and then 1, 2, 3 and 6 months after the end of the study. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Manouchehr Awatef Fazeli

Kermanshah University of Medical Sciences

Mavateffazeli@gmail.com+98 83 3728 3602

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026